Bristol-Myers Squibb News, Bristol-Myers Squibb Quote, BMY Quote

Bristol-Myers Squibb (NY:BMY) Delayed: 60.29 -0.45 (0.74%)

Prev. Close

$60.74

Today 6M 1Y 5Y

Open

$60.43

52 Wk High

$77.12

52 Wk Low

$49.03

Day High

$60.43

Day Low

$59.45

P/E

39.15

EPS

$1.54

Volume

11,401,701

Friends, Peers and Foes (?): PFE, LLY, ABBV, MRK, AMGN (more...)

ALERTS | RSS

Mar 6, 2026 09:59 PM FDA approves Bristol Myers Squibb's Sotyktu for psoriatic arthritis
Mar 6, 2026 09:59 PM U.S. FDA Approves Bristol Myers Squibb’s Sotyktu® (deucravacitinib) for the Treatment of Adults with Active Psoriatic Arthritis
Mar 6, 2026 07:44 AM Bristol-Myers Squibb Co. (BMY) PT Raised to $70 at UBS Ahead of Major Catalyst
Mar 3, 2026 04:25 PM Form 4 BRISTOL MYERS SQUIBB CO For: Feb 27 Filed by: Hickey Benjamin
Mar 2, 2026 04:16 PM Bristol-Myers Squibb (BMY) Declares $0.63 Quarterly Dividend; 4% Yield
Mar 2, 2026 04:16 PM Bristol Myers Squibb Announces Dividend
Feb 26, 2026 01:25 PM Stifel Earlier Defended Tango Therapeutics Inc. (TNGX) Amid 12pct Decline
Feb 26, 2026 06:59 AM Iza-bren meets dual endpoints in phase III breast cancer trial
Feb 26, 2026 06:59 AM SystImmune and Bristol Myers Squibb Highlight Positive Phase III Interim Topline Results for izalontamab brengitecan (Iza-bren) in Previously Treated Unresectable Locally Advanced or Metastatic Triple
Feb 24, 2026 04:03 PM RBC Capital Starts Bristol-Myers Squibb Co. (BMY) at Sector Perform

Entities mentioned with BMY

View All Entities